Clinical Trials Directory

Trials / Unknown

UnknownNCT03680651

Frequency and Type of Genetic Abnormalities Found in Antenatal Corpus Callosum Malformation

Status
Unknown
Phase
Study type
Observational
Enrollment
275 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Corpus callosum malformation (CCM) is the most frequently detected cerebral defect diagnosed in the prenatal setting. The most common CCM is corpus callosum agenesis (CCA) which is found in 2 to 3% of patients presenting with intellectual disability. When CCM is diagnosed, the risk of chromosomal disorder is estimated to be 16%, be it aneuploidy such as trisomy 18, trisomy 13 or mosaic trisomy 8, or a chromosome structure anomaly, copy number variation or more complex rearrangement In France, since 2013 oligoarray-based comparative genomic hybridization (aCGH) analysis is performed in the prenatal period for most malformations after approval by a multidisciplinary prenatal diagnosis ethics committee (Centre Pluridisciplinaire de Diagnostic Prénatal, CPDPN) . However, to date only a few studies have been published which report recurrent Copy Number Variations (CNV) associated with CCM and estimate the risk for a chromosomal disorder, thus making counseling difficult in this context of prenatal diagnosis.

Conditions

Timeline

Start date
2018-06-18
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2018-09-21
Last updated
2018-09-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03680651. Inclusion in this directory is not an endorsement.

Frequency and Type of Genetic Abnormalities Found in Antenatal Corpus Callosum Malformation (NCT03680651) · Clinical Trials Directory